Literature DB >> 23381465

Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma: characterization of five cases.

M Fernanda Amary1, Paul O'Donnell, Fitim Berisha, Roberto Tirabosco, Tim Briggs, Rob Pollock, Adrienne M Flanagan.   

Abstract

OBJECTIVE: To describe the imaging and histopathology of pseudomyogenic hemangioendothelioma.
MATERIALS AND METHODS: Five cases of pseudomyogenic hemangioendothelioma, which presented over the last 5 years, were retrieved from the files of the Royal National Orthopaedic Hospital. The imaging and histopathology were reviewed in all cases. Magnetic resonance imaging, which was available from all cases, was assessed for the following features: the number of lesions, location in soft tissue (superficial and or deep/subfascial) and bone, and the signal characteristics and morphology of individual lesions. Immunohistochemistry was performed in all cases to characterize the lesions.
RESULTS: Four of the five patients had multiple lesions involving a single limb. Bone was involved in 3 of the 5 individuals. All tumors diffusely expressed ERG and cytokeratins AE1/3, but not MNF116. CD31 was weakly positive in 4 cases. INI-1 expression was retained in all cases. Imaging features included ill-defined, infiltrative lesions in subcutaneous fat with extension to the adjacent skin, poor- to well-defined intramuscular nodules and predominantly intracortical focal bone lesions with rare medullary involvement.
CONCLUSION: Pseudomyogenic hemangioendothelioma represents a distinct recently characterized tumor type presenting in young adults, with a tendency towards multicentric bone and soft tissue involvement.

Entities:  

Mesh:

Year:  2013        PMID: 23381465     DOI: 10.1007/s00256-013-1577-8

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  19 in total

1.  The fibroma-like variant of epithelioid sarcoma. A fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors.

Authors:  J M Mirra; S Kessler; S Bhuta; J Eckardt
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

2.  ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.

Authors:  Markku Miettinen; Zeng-Feng Wang; Anders Paetau; Shyh-Han Tan; Albert Dobi; Shiv Srivastava; Isabell Sesterhenn
Journal:  Am J Surg Pathol       Date:  2011-03       Impact factor: 6.394

Review 3.  Epithelioid hemangioendothelioma and related lesions.

Authors:  S W Weiss; K G Ishak; D H Dail; D E Sweet; F M Enzinger
Journal:  Semin Diagn Pathol       Date:  1986-11       Impact factor: 3.464

4.  The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.

Authors:  Asem Shalaby; Nadège Presneau; Hongtao Ye; Dina Halai; Fitim Berisha; Bernadine Idowu; Andreas Leithner; Bernadette Liegl; Timothy R W Briggs; Krisztian Bacsi; Lars-Gunnar Kindblom; Nicholas Athanasou; Maria Fernanda Amary; Pancras C W Hogendoorn; Roberto Tirabosco; Adrienne M Flanagan
Journal:  J Pathol       Date:  2010-12-10       Impact factor: 7.996

5.  A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.

Authors:  Costantino Errani; Lei Zhang; Yun Shao Sung; Mihai Hajdu; Samuel Singer; Robert G Maki; John H Healey; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2011-05-16       Impact factor: 5.006

6.  Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis.

Authors:  L R Zukerberg; B J Nickoloff; S W Weiss
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

7.  Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment.

Authors:  D R Chase; F M Enzinger
Journal:  Am J Surg Pathol       Date:  1985-04       Impact factor: 6.394

8.  Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma.

Authors:  Lisa L Lyons; Paula E North; Fernand Mac-Moune Lai; Mark H Stoler; Andrew L Folpe; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

9.  Vascular tumors of bone: A study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma.

Authors:  Harry L Evans; A Kevin Raymond; Alberto G Ayala
Journal:  Hum Pathol       Date:  2003-07       Impact factor: 3.466

10.  Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases.

Authors:  Andrea T Deyrup; Mourad Tighiouart; Anthony G Montag; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2008-06       Impact factor: 6.394

View more
  12 in total

Review 1.  An aggressive case of pseudomyogenic haemangioendothelioma of bone with pathological fracture and rapidly progressive pulmonary metastatic disease: case report and review of the literature.

Authors:  Asad Rabbani Shah; Malee Fernando; Rachel Musson; Nikhil Kotnis
Journal:  Skeletal Radiol       Date:  2015-05-17       Impact factor: 2.199

2.  A novel treatment for bone lesions of multifocal epithelioid sarcoma-like hemangioendothelioma.

Authors:  Adrian T Davis; A Mary Guo; Nancy J Phillips; David D Greenberg
Journal:  Skeletal Radiol       Date:  2015-01-08       Impact factor: 2.199

3.  Lower-Extremity Pseudomyogenic Hemangioendothelioma on Bone Scintigraphy and PET/CT.

Authors:  Simone Krebs; Serena Monti; Natasha Lewis; Alessandro Luciano; Lapo Rastrelli; Lorenzo Mannelli
Journal:  Clin Nucl Med       Date:  2017-05       Impact factor: 7.794

4.  Pseudomyogenic hemangioendothelioma: A misleading vascular tumor.

Authors:  Farah Sassi; Ghada Sahraoui; Lamia Charfi; Olfa Jaidane; Karima Mrad; Raoudha Doghri
Journal:  Int J Surg Case Rep       Date:  2022-09-12

5.  Oral Pseudomyogenic Hemangioendothelioma: Case Report and Review of the Literature.

Authors:  Austin J Shackelford; Carleigh R Canterbury; Michael A Perrino; Joseph Wang; Elizabeth M Philipone; Scott M Peters
Journal:  Head Neck Pathol       Date:  2020-02-03

6.  Expanding the Spectrum of Genetic Alterations in Pseudomyogenic Hemangioendothelioma With Recurrent Novel ACTB-FOSB Gene Fusions.

Authors:  Narasimhan P Agaram; Lei Zhang; Paolo Cotzia; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-12       Impact factor: 6.394

Review 7.  Pseudomyogenic hemangioendothelioma with bone and soft tissue involvement with favorable response to pamidronate: a case report and systematic review of the literature.

Authors:  María Lorena Brance; Nicolás M Cóccaro; Pablo Roitman; Alejandro Castiglioni; Florencia Agostinis; Mariel Spense; Bárbara Scheitlin; Nicholas Rene; Lucas R Brun
Journal:  Arch Osteoporos       Date:  2022-02-01       Impact factor: 2.617

8.  Pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma of the lower limb: report of a rare case.

Authors:  Chuifeng Fan; Lianhe Yang; Xuyong Lin; Enhua Wang
Journal:  Diagn Pathol       Date:  2015-08-28       Impact factor: 2.644

9.  Differential CT and MR imaging diagnosis between low- and high-grade malignant vascular tumors of bone.

Authors:  Jian-Xia Xu; Li Yang; Ying Chen; Mohamad Wasil Peeroo; Xiu-Liang Zhu; Yan-Biao Fu; Ri-Sheng Yu
Journal:  Springerplus       Date:  2016-10-12

10.  Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma.

Authors:  Jason Joseph; Wei-Lien Wang; Madhavi Patnana; Naveen Ramesh; Robert Benjamin; Shreyaskumar Patel; Vinod Ravi
Journal:  Clin Sarcoma Res       Date:  2015-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.